July 04, 2025 a 01:00 pm

BAX: Fundamental Ratio Analysis - Baxter International Inc.

Baxter International Inc. Stock Overview

Baxter International Inc. focuses on a broad array of healthcare products worldwide. The stock is currently rated as "Hold" with moderate potential for growth. Investors should consider both its stable healthcare solutions and presence in over 100 countries.

Fundamental Rating

According to the latest data, Baxter holds a fundamental rating of "C", suggesting average performance. Detailed scores in various financial ratios indicate some challenges in profitability and financial management.

Category Score Visual
Discounted Cash Flow 4
Return on Equity 1
Return on Assets 1
Debt to Equity 1
Price to Earnings 1
Price to Book 3

Historical Rating

Comparing recent scores with previous data shows consistency in discount cash flow but stagnation in other areas.

Date Overall DCF ROE ROA Debt to Equity P/E P/B
2025-07-03 2 4 1 1 1 1 3
Previous 0 4 1 1 1 1 3

Analyst Price Targets

Analyst estimates show a high target of \$98, with a median at \$44.5, revealing a cautious market approach.

High Low Median Consensus
$98 $30 $44.5 $59.07
Baxter Stock Chart

Analyst Sentiments

Baxter maintains a "Hold" consensus with a balanced distribution of buy and hold recommendations.

Rating Count Visual
Strong Buy 0
Buy 16
Hold 19
Sell 1
Strong Sell 0

Conclusion

Baxter International Inc. is a stable entity in the healthcare sector with diverse operations spanning globally. Despite its expansive reach, financial and efficiency metrics suggest room for improvement. The "Hold" recommendation reflects a balanced outlook. Investors should note the company's core strengths in dialysis and critical care products but remain aware of financial constraints impacting potential growth.